CYTEK BIOSCIENCES, INC. Repayments of Debt
CYTEK BIOSCIENCES, INC. (CTKB) reported Repayments of Debt of $2.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. repayments of debt for the quarter ending 2026-06-30 was $1.61M, a 1035.92% increase year-over-year.
- CYTEK BIOSCIENCES, INC. repayments of debt for the quarter ending 2026-03-31 was $869.00K, a 42.75% decline year-over-year.
- CYTEK BIOSCIENCES, INC. repayments of debt for the quarter ending 2025-12-31 was $2.94M, a 2015.11% increase year-over-year.
- CYTEK BIOSCIENCES, INC. repayments of debt for the quarter ending 2025-09-30 was $145.00K, a 3.57% increase year-over-year.
- CYTEK BIOSCIENCES, INC. repayments of debt for fiscal 2025 was $4.75M, a 751.89% increase from fiscal 2024.
- CYTEK BIOSCIENCES, INC. repayments of debt for fiscal 2024 was $557.00K, a 1.42% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. repayments of debt for fiscal 2023 was $565.00K, a 1030.00% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. repayments of debt for fiscal 2022 was $50.00K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.48M 10-Q · filed 2026-08-05 | $5.42M derived: sum of 3 quarters · filed 2026-08-05 | $5.57M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $869.00K 10-Q · filed 2026-05-07 | $3.81M derived: sum of 2 quarters · filed 2026-05-07 | $3.95M derived: sum of 3 quarters · filed 2026-05-07 | $4.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.08M derived: sum of 2 quarters · filed 2026-02-26 | $3.23M derived: sum of 3 quarters · filed 2026-08-05 | $4.75M 10-K · filed 2026-02-26 |
| 2025-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $287.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.80M 10-Q · filed 2025-11-05 | $1.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.66M 10-Q · filed 2026-08-05 | $1.80M derived: sum of 3 quarters · filed 2026-08-05 | $1.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.52M 10-Q · filed 2026-05-07 | $1.66M derived: sum of 2 quarters · filed 2026-05-07 | $1.80M derived: sum of 3 quarters · filed 2026-05-07 | $1.94M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $279.00K derived: sum of 2 quarters · filed 2026-02-26 | $418.00K derived: sum of 3 quarters · filed 2026-02-26 | $557.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $279.00K derived: sum of 2 quarters · filed 2025-11-05 | $418.00K 10-Q · filed 2025-11-05 | $558.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $278.00K 10-Q · filed 2025-08-06 | $418.00K derived: sum of 3 quarters · filed 2026-02-26 | $556.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $139.00K 10-Q · filed 2025-05-08 | $279.00K derived: sum of 2 quarters · filed 2026-02-26 | $417.00K derived: sum of 3 quarters · filed 2026-02-26 | $558.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $278.00K derived: sum of 2 quarters · filed 2026-02-26 | $419.00K derived: sum of 3 quarters · filed 2026-02-26 | $565.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $279.00K derived: sum of 2 quarters · filed 2024-11-07 | $425.00K 10-Q · filed 2024-11-07 | $475.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $287.00K 10-Q · filed 2024-08-06 | $337.00K derived: sum of 3 quarters · filed 2025-02-28 | $337.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $146.00K 10-Q · filed 2024-05-08 | $196.00K derived: sum of 2 quarters · filed 2025-02-28 | $196.00K derived: sum of 3 quarters · filed 2025-02-28 | $196.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $50.00K derived: sum of 2 quarters · filed 2025-02-28 | $50.00K derived: sum of 3 quarters · filed 2025-02-28 | $50.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |